Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study
EU, European Federation of Pharmaceutical Industries and the Associations Innovative Medicines Initiative Inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis Consortium, European Respiratory Society.
Authors
- Wim Boersma (ORCID: https://orcid.org/0000-0002-7908-9612)
- Arietta Spinou (ORCID: https://orcid.org/0000-0002-3442-4739)
- Lucy Burr (ORCID: https://orcid.org/0000-0003-4010-3787)
- Michael R. Loebinger
- Josje Altenburg (ORCID: https://orcid.org/0000-0002-7248-963X)
- Jeremy Brown (ORCID: https://orcid.org/0000-0002-5650-5361)
- Michal Shteinberg (ORCID: https://orcid.org/0000-0002-0432-3398)
- Kateryna Viligorska
- Lídia Perea (ORCID: https://orcid.org/0000-0002-1624-0012)
- Raúl Méndez (ORCID: https://orcid.org/0000-0001-6300-9836)
- Menno M. van der Eerden (ORCID: https://orcid.org/0000-0002-8407-2524)
- John Robert Hurst (ORCID: https://orcid.org/0000-0002-7246-6040)
- Charles Haworth (ORCID: https://orcid.org/0000-0001-7126-2874)
- J.S. Elborn (ORCID: https://orcid.org/0000-0002-2323-442X)
- Felix C. Ringshausen (ORCID: https://orcid.org/0000-0001-9084-4968)
- Jin‐Fu Xu (ORCID: https://orcid.org/0000-0002-8039-8973)
- Raja Dhar (ORCID: https://orcid.org/0000-0002-6742-5674)
- Eva Polverino (ORCID: https://orcid.org/0000-0002-4058-5109)
- Holly Lind
- Katerina Dimakou (ORCID: https://orcid.org/0000-0001-7457-4611)
- Noel Karalus
- Jamie Stobo
- Paula Kauppi (ORCID: https://orcid.org/0000-0002-1065-330X)
- Pieter Goeminne (ORCID: https://orcid.org/0000-0001-6220-2220)
- Apostolos Bossios (ORCID: https://orcid.org/0000-0002-0494-2690)
- Lata Jayaram (ORCID: https://orcid.org/0000-0002-6656-6045)
- Natalie Lorent (ORCID: https://orcid.org/0000-0002-2653-5885)
- Sanjay H. Chotirmall (ORCID: https://orcid.org/0000-0003-0417-7607)
- Montserrat Vendrell (ORCID: https://orcid.org/0000-0002-6879-5757)
- Steven Taylor (ORCID: https://orcid.org/0000-0003-4357-8243)
- Anthony De Soyza (ORCID: https://orcid.org/0000-0002-8566-0344)
- Lotte Terpstra (ORCID: https://orcid.org/0000-0001-7010-7071)
- Yong‐hua Gao (ORCID: https://orcid.org/0000-0002-8140-1679)
- Hayoung Choi (ORCID: https://orcid.org/0000-0003-4812-0653)
- Conroy Wong (ORCID: https://orcid.org/0000-0003-2227-1170)
- Pierre‐Régis Burgel (ORCID: https://orcid.org/0000-0003-0903-9828)
- Stefano Aliberti (ORCID: https://orcid.org/0000-0002-0090-4531)
- Antoni Torres (ORCID: https://orcid.org/0000-0002-5649-7699)
- Francesco Blasi (ORCID: https://orcid.org/0000-0001-9406-1784)
- James D. Chalmers (ORCID: https://orcid.org/0000-0001-5514-7868)
- Oriol Sibila
- Emma D Johnson
- Megan Martin
Institutions
- Tongji University (CN)
- Queen's University Belfast (GB)
- Mater Health Services (AU)
- University of Helsinki (FI)
- King's College London (GB)
- Fudan University (CN)
- Helsinki University Hospital (FI)
- Middlemore Hospital (NZ)
- Waikato Hospital (NZ)
- Erasmus MC (NL)
- Ninewells Hospital (GB)
- Hallym University Kangnam Sacred Heart Hospital (KR)
- Huadong Hospital (CN)
- Papworth Hospital NHS Foundation Trust (GB)
- Counties Manukau District Health Board (NZ)
- Vlaamse Vereniging voor Obstetrie en Gynaecolo (BE)
- Shanghai Pulmonary Hospital (CN)
- South Australian Health and Medical Research Institute (AU)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- University College London (GB)
- Universitat de Barcelona (ES)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- The Lancet Respiratory Medicine
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1016/s2213-2600(25)00160-2
- Citations
- 8
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 12.15
Funders
- Pfizer
- AstraZeneca
- Sanofi
- CSL Behring
- European Respiratory Society
- LifeArc
- European Federation of Pharmaceutical Industries and Associations
- Insmed
- European Commission
- Grifols
- Horizon 2020 Framework Programme
- Medical Research Council